Incidence of new coronary events in older persons with diabetes mellitus and prior myocardial infarction treated with sulfonylureas, insulin, metformin, and diet alone
- 1 September 2001
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 88 (5) , 556-557
- https://doi.org/10.1016/s0002-9149(01)01739-8
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarctionPublished by Elsevier ,2006
- Relation between sulfonylurea therapy, complications, and outcome for elderly patients with acute myocardial infarctionAmerican Heart Journal, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998
- Report of the Expert Committee on the Diagnosis and Classification of Diabetes MellitusDiabetes Care, 1997
- Oral Sulfonylurea Hypoglycemic Agents Prevent Ischemic Preconditioning in Human MyocardiumCirculation, 1997
- Sulfonylurea K ATP Blockade in Type II Diabetes and Preconditioning in Cardiovascular DiseaseCirculation, 1996
- Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker.Circulation, 1994
- Prevalence of presenting symptoms of recognized acute myocardial infarction and of unrecognized healed myocardial infarction in elderly patientsThe American Journal of Cardiology, 1987
- A Summary of Criticisms of the Findings and Conclusions of the University Group Diabetes Program (UGDP)Diabetes, 1972